Free Trial
NYSE:STE

STERIS (STE) Stock Price, News & Analysis

STERIS logo
$241.74 +1.52 (+0.63%)
As of 01:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About STERIS Stock (NYSE:STE)

Key Stats

Today's Range
$238.20
$243.08
50-Day Range
$222.23
$252.31
52-Week Range
$200.98
$252.79
Volume
447,319 shs
Average Volume
588,773 shs
Market Capitalization
$23.78 billion
P/E Ratio
38.99
Dividend Yield
0.94%
Price Target
$263.83
Consensus Rating
Moderate Buy

Company Overview

STERIS plc is a global provider of infection prevention, contamination control and surgical support equipment and services headquartered in Dublin, Ireland, with major operations in Mentor, Ohio. The company develops and delivers a wide range of products and solutions designed to support the healthcare, pharmaceutical, medical device and research industries in maintaining clean and safe environments. Its core offerings include sterilization equipment, surgical instrumentation, single-use sterile products and comprehensive service and validation programs.

In its healthcare segment, STERIS supplies hospitals, ambulatory surgery centers and physician offices with steam and low-temperature sterilizers, endoscope reprocessing systems, surgical tables, lights and equipment management solutions. The life sciences and pharmaceutical segment addresses critical contamination control needs for drug and device manufacturers through cleanroom solutions, washer-disinfectors, isolators, safety-engineered stoppers, sealing systems and contract sterilization services for oxygen and hydrogen peroxide cycles.

Founded in 1985 as STERIS Corporation and later restructured as an Ireland-domiciled public limited company following the 2019 merger with UK-based Synergy Health, the firm has grown its footprint through strategic acquisitions and organic investment in research and development. Past acquisitions include Key Surgical, Integrated Medical Systems Corporation and Cantel Medical’s sterilization business. James P. Lawrence, appointed President and Chief Executive Officer in 2014, leads an executive team focused on innovation, regulatory compliance and global expansion.

STERIS operates in more than 25 countries with manufacturing facilities, service centers and distribution networks spanning North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. The company’s service organization delivers on-site maintenance, validation, asset management and training, while its global regulatory and quality teams support customers in meeting stringent regional and international standards.

AI Generated. May Contain Errors.

STERIS Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

STE MarketRank™: 

STERIS scored higher than 98% of companies evaluated by MarketBeat, and ranked 71st out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    STERIS has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about STERIS's stock forecast and price target.
  • Earnings Growth

    Earnings for STERIS are expected to grow by 9.36% in the coming year, from $9.08 to $9.93 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STERIS is 38.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STERIS is 38.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.41.

  • Price to Book Value per Share Ratio

    STERIS has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about STERIS's valuation and earnings.
  • Percentage of Shares Shorted

    0.74% of the float of STERIS has been sold short.
  • Short Interest Ratio / Days to Cover

    STERIS has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STERIS has recently decreased by 19.05%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    STERIS has a dividend yield of 0.95%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    STERIS has been increasing its dividend for 20 years.

  • Dividend Coverage

    The dividend payout ratio of STERIS is 36.77%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, STERIS will have a dividend payout ratio of 22.96% next year. This indicates that STERIS will be able to sustain or increase its dividend.

  • Read more about STERIS's dividend.
  • Percentage of Shares Shorted

    0.74% of the float of STERIS has been sold short.
  • Short Interest Ratio / Days to Cover

    STERIS has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STERIS has recently decreased by 19.05%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    STERIS has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for STERIS this week, compared to 11 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, STERIS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,483,389.00 in company stock.

  • Percentage Held by Insiders

    Only 1.07% of the stock of STERIS is held by insiders.

  • Percentage Held by Institutions

    94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about STERIS's insider trading history.
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Stock News Headlines

1 Mid-Cap Stock to Target This Week and 2 to Think Twice About
Gold prediction: $5,000/oz. or higher is coming
The perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an epic bull rally in gold. JP Morgan and Goldman Sachs have a price target of $4,000. My research tells me gold could surpass $5,000 in the coming months. Folks using a very specific gold strategy since the 80s could have made more than 60 TIMES their money. Today, you can take advantage of a similar setup for around $10
STERIS plc (STE)
See More Headlines

STE Stock Analysis - Frequently Asked Questions

STERIS's stock was trading at $205.56 at the beginning of 2025. Since then, STE shares have increased by 16.0% and is now trading at $238.5170.
View the best growth stocks for 2025 here
.

STERIS plc (NYSE:STE) posted its quarterly earnings results on Wednesday, May, 14th. The medical equipment provider reported $2.74 EPS for the quarter, beating analysts' consensus estimates of $2.59 by $0.15. STERIS's revenue for the quarter was up 5.7% compared to the same quarter last year.
Read the conference call transcript
.

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STERIS investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Visa (V), Home Depot (HD) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/14/2025
Record date for 6/26 Dividend
6/10/2025
Ex-Dividend for 6/26 Dividend
6/10/2025
Dividend Payable
6/26/2025
Today
7/01/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:STE
Employees
17,787
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$263.83
High Stock Price Target
$280.00
Low Stock Price Target
$250.00
Potential Upside/Downside
+9.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
39.04
Forward P/E Ratio
26.62
P/E Growth
N/A
Net Income
$614.64 million
Pretax Margin
14.58%

Debt

Sales & Book Value

Annual Sales
$5.46 billion
Cash Flow
$14.43 per share
Price / Cash Flow
16.75
Book Value
$67.33 per share
Price / Book
3.59

Miscellaneous

Free Float
97,318,000
Market Cap
$23.78 billion
Optionable
Optionable
Beta
0.94

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NYSE:STE) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners